Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816601) titled 'Donor Breast Milk 2' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: AdventHealth
Condition:
Iron Deficiency Anemia
Intervention:
Drug: Ferrous Sulfate Oral Product
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 6, 2026
Target Sample Size: 17
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07816601
Published by HT Digital Content Services with permission from Health Daily Digest....